Загрузка...
Can Standardisation of the Public Assessment Report Improve Benefit-Risk Communication?
BACKGROUND: National regulatory authorities (NRAs) make the decision to register a medicine based on an assessment of its benefits and risks and publicly available assessment reports are used as a tool to communicate the basis for the decision. The Universal Methodology for Benefit-Risk Assessment (...
Сохранить в:
| Опубликовано в: : | Front Pharmacol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7313675/ https://ncbi.nlm.nih.gov/pubmed/32625087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00855 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|